To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

Part of paid clinical trials in Huntsville, Alabama.

Sponsor
Jazz Pharmaceuticals
Study ID
NCT04894591
Status
Completed

Conditions

  • Extensive-stage Small-cell Lung Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Zepzelca — DRUG
    Zepzelca is administered by intravenous infusion over 60 minutes every 21 days. Date, dose prescribed and received will be collected at each Zepzelca infusion.

Study Details

To assess the effectiveness and safety of Zepzelca in adult participants with extensive stage small cell lung cancer (SCLC) in real-world clinical practice.

Key Dates

Start date
Jun 28, 2021
Status verified
Feb 2026
Primary completion
Jun 4, 2025
Completion
Jun 4, 2025

Study Design

Enrollment
272 participants (actual)

Primary Outcome Measure

Overall Response Rate (ORR) [ Time Frame: up to 6 months after first infusion ]

Locations (32)

FacilityCityStateZIPSite coordinators
Clearview Cancer InstituteHuntsvilleAlabama35805-
Eastern Connecticut Hematology and OncologyNorwichConnecticut06360-
ASCLEPES Research CentersBrooksvilleFlorida34613-
Woodlands Medical Specialists - Woodlands Center For Specialized MedicinePensacolaFlorida32503-
Mid-Illinois Hematology & Oncology AssociatesNormalIllinois61761-
Goshen Health Center for Cancer CareGoshenIndiana46526-
Siouxland Regional Cancer Center dba June E. Nylen Cancer CenterSioux CityIowa51101-
Stormont-Vail Cancer Center-Stormont-Vail Healthcare - Cotton-O'Neil Cancer CenterTopekaKansas66606-
Cancer Center of KansasWichitaKansas67214-
Baptist Health LexingtonLexingtonKentucky40503-
Pikeville Medical Center - Leonard Lawson Cancer CenterPikevilleKentucky41501-
West Jefferson Cancer CenterMarreroLouisiana70072-
MMCORC - HealthPartners InstituteSaint Louis ParkMinnesota55416-
Singing River Health SystemPascagoulaMississippi39581-
Central Care Cancer CenterBolivarMissouri65613-
Benefis Medical GroupGreat FallsMontana59405-
Regional Cancer Care Associates LLC (RCCA)HackensackNew Jersey07601-
Center for Clinical Research-Rochester General HospitalRochesterNew York14625-
Montefiore Medical Center (MMC) - Montefiore Medical Park (MMP)The BronxNew York10461-
University of North Carolina NASH Cancer CenterRocky MountNorth Carolina27804-
Trinity Cancercare CenterMinotNorth Dakota58701-
Gabrail Cancer Center ResearchCantonOhio44718-
Tri-County Hematology & Oncology Associates, IncMassillonOhio44646-
Lankenau Institute for Medical ResearchWynnewoodPennsylvania19096-
Charleston Hematology Oncology Associates, PACharlestonSouth Carolina29414-
Carolina Blood & Cancer Care AssociatesRock HillSouth Carolina29732-
Lexington Oncology AssociatesWest ColumbiaSouth Carolina29169-
Monument Health Cancer Care InstituteRapid CitySouth Dakota57701-
Baptist Cancer CenterMemphisTennessee38120-
Baylor Scott & White Medical Center - TempleTempleTexas76508-
Tranquil Clinical ResearchWebsterTexas77598-
ThedaCare Regional Cancer CenterAppletonWisconsin54911-

Find similar trials in Huntsville, AL

By research site
Clearview Cancer Institute· Huntsville, ALEastern Connecticut Hematology and Oncology· Norwich, CTASCLEPES Research Centers· Brooksville, FLWoodlands Medical Specialists - Woodlands Center For Specialized Medicine· Pensacola, FLMid-Illinois Hematology & Oncology Associates· Normal, ILGoshen Health Center for Cancer Care· Goshen, IN

Related Studies